Drugline is a fortnightly electronic drug bulletin for health professionals.


Drugline is a fortnightly electronic drug bulletin providing information on new medicines, new developments, current affairs, new indications, new PBS listings and deletions and general issues of importance to all health professionals. Click below to view the most recent volumes of Drugline.

Semaglutide on the PBS

Drugline Volume 399

Semaglutide is the latest glucagon-like peptide-1 (GLP-1) analogue to be added to the Pharmaceutical Benefits Scheme (PBS). GLP-1 is an incretin hormone that stimulates the release of insulin and inhibits the release of glucagon…

Read more

Updates to the PBS criteria for evolocumab

Drugline Volume 398

Evolocumab is now available on the Pharmaceutical Benefits Scheme (PBS) for high-risk atherosclerotic cardiovascular disease (ASCVD) in non-familial hypercholesterolaemia. The PBS criteria must include low-density lipoprotein (LDL) levels >2.6mmol/L, symptomatic ASCVD with additional risk factors and the patient must…

Read more

Updated PBS-listing for Trifluridine / Tipiracil in treatment of pre-treated metastatic gastric cancer including gastroesophageal junction cancer

Drugline Volume 397

Trifluridine/tipiracil is now available on the Pharmaceutical Benefits Scheme (PBS) for pre-treated cancer of the stomach or gastro-oesophageal junction. In the TAGS trial, trifluridine/tipiracil was demonstrated to significantly prolong overall survival in pre-treated gastric…

Read more

Combination Inhaler for Mild Asthma

Drugline Volume 396

The Pharmaceutical Benefits Scheme (PBS) has recently expanded the listing criteria for Symbicort®. Symbicort® contains the corticosteroid, budesonide plus the long-acting β2-agonist (LABA), formoterol. The new PBS listing allows Symbicort® to be used as reliever therapy in the management of…

Read more

Insulin Glargine on the PBS

Drugline Volume 395

From 1st July 2020, Lantus® products will no longer be available on the Pharmaceutical Benefits Scheme (PBS). Lantus® contains insulin glargine, a long-acting insulin analogue that is indicated for the management of type 1…

Read more

PBS Changes for Common Antibiotics

Drugline Volume 394

The Pharmaceutical Benefits Scheme (PBS) has recently made changes to the listings of some commonly prescribed antibiotics. These updates are in response to a Department of Health review in which one in five repeat…

Read more
Load More

July 2020

May 2020

March 2020

December 2019

November 2019

October 2019

New Warning for Febuxostat (Oct. 18 2019)

Naloxone Nasal Spray (Oct. 04 2019)

April 2019

New High-Strength Insulin (Apr. 18 2019)

Tofacitinib Safety Issue (Apr. 05 2019)

March 2019

February 2019

January 2019

December 2018

October 2018

September 2018

August 2018

July 2018

April 2018

January 2018

December 2017

September 2017

Thunderstorm Asthma (Sep. 21 2017)

The Efficacy of Perampanel (Sep. 08 2017)

July 2017

June 2017

April 2017

March 2017

November 2016

September 2016

August 2016

April 2016

November 2015

Viekira Pak for Hepatitis C (Nov. 19 2015)

Micafungin (Nov. 05 2015)

October 2015

Dabigatran Antidote on the Horizon (Oct. 22 2015)

Akynzeo® (Oct. 08 2015)

September 2015

May 2015

April 2015

Victoza (liraglutide) (Apr. 23 2015)

Ultibro Breezhaler 100/50 (Apr. 09 2015)

March 2015

February 2015

December 2014

November 2014

October 2014

September 2014

World Pharmacist Day (Sep. 24 2014)

National Stroke Week (Sep. 11 2014)

August 2014

July 2014

Breo™ Ellipta® (Jul. 31 2014)

Use of Prolia® in Men (Jul. 17 2014)

Adcetris® (brentuximab vedotin) (Jul. 03 2014)

April 2014

March 2014

September 2013

August 2013

July 2013

June 2013

Riluzole for Motor Neurone Disease (Jun. 20 2013)

Mycamine (Jun. 06 2013)

May 2013

HPV Vaccine (May. 23 2013)

World Lupus Day (May. 09 2013)

December 2012

November 2012

August 2012